Matinas BioPharma Holdings, Inc.
MTNB · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,532 | -$5,245 | -$1,656 | -$8,433 |
| Dep. & Amort. | $111 | -$98 | $128 | $247 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $238 | $315 | $244 |
| Change in WC | -$220 | -$481 | -$500 | $86 |
| Other Non-Cash | $167 | $3,565 | -$294 | $4,346 |
| Operating Cash Flow | -$1,474 | -$2,021 | -$2,007 | -$3,510 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $500 |
| Other Inv. Act. | $320 | $0 | $0 | $0 |
| Investing Cash Flow | $320 | $0 | $0 | $500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1 | -$1 | -$1 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $64 | $1,623 | $1,648 | $0 |
| Financing Cash Flow | $64 | $1,622 | $1,647 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,090 | -$399 | -$360 | -$3,011 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,775 | $7,174 | $7,534 | $10,545 |
| End Cash | $5,685 | $6,775 | $7,174 | $7,534 |
| Free Cash Flow | -$1,474 | -$2,021 | -$2,007 | -$3,510 |